Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI)

CAPS Rating: 5 out of 5

A biopharmaceutical company that acquires and advances a diversified portfolio of drug candidates, with a focus on oncology, urology and other critical health challenges for which there are few other treatment options.

Recs

0
Player Avatar gotham83 (< 20) Submitted: 6/21/2011 11:12:49 AM : Outperform Start Price: $8.46 SPPI Score: +30.40

Even if not taken over by Big Pharma, this is one worth paying attention to.

Featured Broker Partners


Advertisement